Fig 1.
Flowchart showing categories of treatment-seeking behavior of people with NCC-associated epilepsy and NCC-associated severe chronic headaches in Mexico.
Note: Please refer to Table 1 for information concerning the uncertainty distributions associated with the specific parameters. All data were stratified by rural/urban residence. Localities of 2,500 or more inhabitants were considered urban (UN 2010).
Table 1.
Human epidemiologic parameters used to estimate the monetary burden of cysticercosis in Mexico.
Table 2.
Parameters associated with productivity losses in people with NCC-associated epilepsy or severe chronic headaches in Mexico.
Table 3.
Epidemiologic parameters used to estimate the monetary burden of porcine cysticercosis in Mexico.
Table 4.
Economic parameters used to estimate the monetary burden of cysticercosis in Mexico (in 2015 U.S.$).
Table 5.
Estimated number of NCC-associated epilepsy and NCC-associated severe chronic headaches cases in 2015 in Mexico along with their 95% Credible Regions (CR).
Table 6.
Total direct costs and the cost per patient for people with NCC-associated epilepsy and NCC-associated severe chronic headaches who received modern medical treatment in 2015 along with their 95% CRs (in 2015 U.S.$).
Table 7.
Total indirect costs and the cost per patient for people with NCC-associated epilepsy and NCC-associated severe chronic headaches who received modern medical treatment in 2015 along with their 95% CRs (in 2015 U.S.$).
Fig 2.
Sensitivity analysis for the estimated cost of cysticercosis in Mexico.
Table 8.
Comparison of disease burden estimates due to T. solium cystercosis in Mexico with other countries.